|
|
|
Insider
Information: |
Roche Robert P Jr |
Relationship: |
Director |
City: |
West Chester |
State: |
PA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
50,582 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
50,582 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cephalon Inc |
CEPH |
Exec. VP, WW Pharm Ops |
2009-12-21 |
50,582 |
2003-09-08 |
0 |
Premium* |
|
Lifecell Corp |
LIFC |
Director |
2008-05-19 |
0 |
2006-06-29 |
0 |
Premium* |
|
Antares Pharma Inc |
ATRS |
Director |
2022-05-24 |
0 |
|
0 |
Premium* |
|
Aratana Therapeutics, Inc. |
PETX |
Director |
2019-07-18 |
0 |
2016-06-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CEPH |
Cephalon Inc |
Exec. VP, WW Pharm Ops |
|
2008-08-11 |
4 |
OE |
$48.06 |
$1,080,083 |
D/D |
21,676 |
61,885 |
0 |
- |
|
CEPH |
Cephalon Inc |
Exec. VP, WW Pharm Ops |
|
2008-08-11 |
4 |
S |
$76.96 |
$1,668,185 |
D/D |
(21,676) |
40,209 |
0 |
- |
|
CEPH |
Cephalon Inc |
Exec. VP, WW Pharm Ops |
|
2008-12-01 |
4 |
D |
$68.85 |
$103,550 |
D/D |
(1,504) |
38,705 |
0 |
- |
|
CEPH |
Cephalon Inc |
Exec. VP, WW Pharm Ops |
|
2008-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
53,705 |
0 |
- |
|
CEPH |
Cephalon Inc |
Exec. VP, WW Pharm Ops |
|
2008-12-15 |
4 |
D |
$75.29 |
$113,161 |
D/D |
(1,503) |
52,202 |
0 |
- |
|
CEPH |
Cephalon Inc |
Exec. VP, WW Pharm Ops |
|
2008-12-16 |
4 |
D |
$76.35 |
$137,735 |
D/D |
(1,804) |
50,398 |
0 |
- |
|
CEPH |
Cephalon Inc |
EVP, WW Pharm Ops |
|
2008-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
231 |
48,664 |
0 |
- |
|
CEPH |
Cephalon Inc |
EVP, WW Pharm Ops |
|
2008-12-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
34 |
48,630 |
0 |
- |
|
CEPH |
Cephalon Inc |
Exec. VP, WW Pharm Ops |
|
2008-12-19 |
4 |
D |
$77.50 |
$116,483 |
D/D |
(1,503) |
48,895 |
0 |
- |
|
CEPH |
Cephalon Inc |
EVP, WW Pharm Ops |
|
2008-12-22 |
4 |
S |
$77.00 |
$1,845,823 |
D/D |
(23,920) |
41,221 |
0 |
- |
|
CEPH |
Cephalon Inc |
EVP, WW Pharm Ops |
|
2008-12-22 |
4 |
OE |
$48.06 |
$918,452 |
D/D |
18,319 |
65,141 |
0 |
- |
|
CEPH |
Cephalon Inc |
EVP, WW Pharm Ops |
|
2008-12-22 |
4 |
D |
$77.16 |
$139,505 |
D/D |
(1,808) |
46,822 |
0 |
- |
|
CEPH |
Cephalon Inc |
Exec. VP, WW Pharm Ops |
|
2009-12-01 |
4 |
D |
$55.32 |
$62,456 |
D/D |
(1,129) |
40,092 |
0 |
- |
|
CEPH |
Cephalon Inc |
Exec. VP, WW Pharm Ops |
|
2009-12-02 |
4 |
A |
$56.07 |
$841,050 |
D/D |
15,000 |
55,092 |
0 |
- |
|
CEPH |
Cephalon Inc |
Exec. VP, WW Pharm Ops |
|
2009-12-11 |
4 |
D |
$58.94 |
$88,587 |
D/D |
(1,503) |
53,589 |
0 |
- |
|
CEPH |
Cephalon Inc |
Exec. VP, WW Pharm Ops |
|
2009-12-14 |
4 |
D |
$59.13 |
$88,872 |
D/D |
(1,503) |
52,086 |
0 |
- |
|
CEPH |
Cephalon Inc |
Exec. VP, WW Pharm Ops |
|
2009-12-21 |
4 |
D |
$59.75 |
$89,864 |
D/D |
(1,504) |
50,582 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2013-07-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2013-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
18,172 |
23,172 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2014-08-13 |
4 |
B |
$1.96 |
$9,795 |
D/D |
5,000 |
28,172 |
2.39 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2015-08-13 |
4 |
B |
$1.94 |
$9,700 |
D/D |
5,000 |
33,172 |
2.39 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2015-08-24 |
4 |
B |
$1.77 |
$8,850 |
D/D |
5,000 |
38,172 |
2.39 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2016-03-18 |
4 |
B |
$0.72 |
$36,000 |
D/D |
50,000 |
88,172 |
2.39 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
Director |
|
2016-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
4,500 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
Director |
|
2017-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
9,000 |
0 |
- |
|
82 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|